Go Back

National Training Course in Nuclear Cardiology, Nephrology and Neurology

This RTC was held in Havana, Cuba in January 2010. Under the IAEA TC National Project CUB/6/016

The following topics were discussed during the training course. 

The available lectures are highlighted in blue. To open the file please click on the title.

Dynamic images and videos included in the original lectures are not available at the moment.

The following topics were included (most lectures available only in Spanish):

CARDIOLOGY

• Worldwide CVD data and Nuclear Cardiology utilization.

João Vitola, MD, PhD (Brazil), IAEA Expert

• New developments in radiopharmaceuticals and tracers.

Francisco Zayas, PhD (Cuba)

• Multimodality imaging approach to evaluate CAD: US, CT, MRI, SPECT/PET.

Erick Alexanderson, MD (Mexico), IAEA Expert

• State of the art of cardiac CT.

Luis R. Llerena, MD, PhD (Cuba)

• State of the art of Nuclear Cardiology: new cameras and protocols.                       

João Vitola, MD, PhD (Brazil), IAEA Expert

• Intima-media thickness. Usefulness in clinical practice.

Juan Valiente, MD (Cuba)

• CT calcium scoring: complementary to perfusion imaging. Prognostic value.

Erick Alexanderson, MD (Mexico), IAEA Expert

• Clinical Guidelines. How precise are they?

Lydia Rodríguez, BSc (Cuba)

• What do clinicians expect from imaging tests? Experience of a clinical cardiologist.

Kenia Padrón, MD (Cuba)

• Diagnostic algorithms for CAD assessment. When and how to use imaging techniques in a cost-effective manner. Data from clinical trials.

Fernando Mut, MD (Uruguay), IAEA Expert

• Emergency department: When and how to implement MPI.

Lázaro O. Cabrera, MD (Cuba)

• CAD in asymptomatic diabetic patients. Role of Nuclear Cardiology.

Amalia Peix, MD, PhD (Cuba)

• CAD diagnosis in women: How to understand the imaging approach.

Fernando Mut, MD (Uruguay), IAEA Expert

• Viability assessment: scar or jeopardized but viable myocardium as the imaging target?

Juan Batista, MD (Cuba)

• Autonomic Nervous System - MIBG, the impact on heart failure and sudden cardiac death risk stratification.

João Vitola, MD, PhD (Brazil), IAEA Expert

• Clinical Importance of the evaluation of myocardial blood flow with PET.       

Erick Alexanderson, MD (Mexico), IAEA Expert

• Perfusion and non-perfusion risk parameters derived from Gated SPECT.

Fernando Mut, MD (Uruguay), IAEA Expert